The α-PD-1 antibody clone chosen for these experiments (RMP1-14) has been shown to block the binding of mouse PD-L1 and PD-L2 to PD-1 and is widely used in mouse models of cancer immunotherapy (35). Here, CD274 is linked to cancer.